Search


	Podcast:		Diabetes Knowledge into Practice Podcast
	Episode:		Newsflash \| SUSTAIN FORTE: Semaglutide 2mg vs. 1mg in T2D
	Category:		Health
	Duration:		00:05:14
	Publish Date:		2021-07-07 15:18:34
	Description:		In the the latest news episode, we bring you a 5-minute summary of the SUSTAIN FORTE results presented at ADA. This trial investigated whether once-weekly semaglutide 2mg was superior at reducing HbA1c in type 2 diabetes, compared with a 1mg dose. Listen for a quick overview of the key findings. Abstract: Frias J P, et al. Diabetes 2021 Jun; 70(Supplement 1) For more free education, visit the DKIP website, follow us on Twitter (@dkipractice) or connect on LinkedIn. Funding statement: This independent educational activity is supported by an educational grant from Eli Lilly, Merck Sharp and Dohme Corp. and Novo Nordisk A/S. The educational content has been developed by Liberum IME in conjunction with an independent steering committee; the financial supporters have had no influence on the content of this education.
	Total Play:		0